Search

Author/Creator Choi, Yunha

1. A phase II, multicenter, open-label trial to evaluate the safety and efficacy of ISU303 (Agalsidase beta) in patients with Fabry disease. Issue 37 (16th September 2022)

Authors:
Hwang, Soojin; Lee, Beom Hee; Kim, Woo-Shik; Kim, Dae-Seong; Cheon, Chong Kun; Lee, Chang Hwa; Choi, Yunha; Choi, Jin-Ho; Kim, Ja Hye; Yoo, Han-Wook
Journal:
Medicine
Issue:
Volume 101:Issue 37(2022)
Page Start:
e30345
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Identification of a novel therapeutic target underlying atypical manifestation of Gaucher disease. Issue 5 (20th May 2022)

Authors:
Kim, Eun Na; Do, Hyo‐Sang; Jeong, Hwangkyo; Kim, Taeho; Heo, Sun Hee; Kim, Yoo‐Mi; Cheon, Chong Kun; Lee, Yena; Choi, Yunha; Choi, In Hee; Choi, Jeongmin; Yoo, Han‐Wook; Kim, Chong Jai; Zimran, Ari; Kim, Kyunggon; Lee, Beom Hee
Journal:
Clinical and translational medicine
Issue:
Volume 12:Issue 5(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. KBG syndrome: Clinical features and molecular findings in seven unrelated Korean families with a review of the literature. Issue 4 (23rd December 2022)

Authors:
Choi, Yunha; Choi, Jungmin; Do, Hyosang; Hwang, Soojin; Seo, Go Hun; Choi, In Hee; Keum, Changwon; Choi, Jin‐Ho; Kang, Minji; Kim, Gu‐Hwan; Yoo, Han‐Wook; Lee, Beom Hee
Journal:
Molecular genetics & genomic medicine
Issue:
Volume 11:Issue 4(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗